Phlow awarded US$354M BARDA contract for essential medicines manufacturing

Phlow Corporation received a US$354 million base award from BARDA to manufacture essential medicines at risk of shortage, including for COVID-19. The total contract value is up to US$812 million with options.

“Phlow, a U.S.-based, public benefit drug manufacturing corporation, has received federal government funding of $354 million for advanced manufacturing of America's most essential medicines at risk of shortage”prnewswire.com

• 3 sources
• prnewswire.comPhlow Corporation Awarded $354 Million HHS/ASPR/BARDA Contract to Manufacture Essential Medicines in ShortagePhlow Corp.May 19, 2020
• upi.comHHS taps Virginia company to expand U.S. production of crucial drugs - UPI.comDon JacobsonMay 19, 2020
• phlow-usa.comRichmond Startup Awarded $354 Million Federal Contract to Make Ingredients for Covid-19 Drugs - PhlowkarvMay 19, 2020

Summarized from public sources; check the original articles before acting on it.